Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis
出版年份 2022 全文链接
标题
Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis
作者
关键词
-
出版物
Scientific Reports
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-08-17
DOI
10.1038/s41598-022-18278-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Loss of STING expression is prognostic in non–small cell lung cancer
- (2022) Zoltan Lohinai et al. JOURNAL OF SURGICAL ONCOLOGY
- Increased activation of cGAS‐STING pathway enhances radiosensitivity of non‐small cell lung cancer cells
- (2022) Aiying Xue et al. Thoracic Cancer
- LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
- (2022) Yanping Gao et al. Clinical and Translational Medicine
- cGAS-STING pathway expression as a prognostic tool in NSCLC
- (2021) Kristine Raaby Gammelgaard et al. Translational Lung Cancer Research
- RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
- (2021) Xueping Jiang et al. Cell and Bioscience
- Navigating the DNA methylation landscape of cancer
- (2021) Atsuya Nishiyama et al. TRENDS IN GENETICS
- MET amplification attenuates lung tumor response to immunotherapy by inhibiting STING
- (2021) Yong Zhang et al. Cancer Discovery
- DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine
- (2021) Runzhang Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion
- (2021) Antonio Marzio et al. CELL
- Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer
- (2021) Xuewei Yan et al. International Journal of Biological Sciences
- STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype
- (2020) Carminia M. Della Corte et al. Journal of Thoracic Oncology
- Genomic landscape of lung adenocarcinoma in East Asians
- (2020) Jianbin Chen et al. NATURE GENETICS
- LncRNA NEAT1 Interacted With DNMT1 to Regulate Malignant Phenotype of Cancer Cell and Cytotoxic T Cell Infiltration via Epigenetic Inhibition of p53, cGAS, and STING in Lung Cancer
- (2020) Fang Ma et al. Frontiers in Genetics
- Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
- (2020) Henrique Lemos et al. Journal for ImmunoTherapy of Cancer
- A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I–III colon cancer
- (2019) Rui Zhou et al. EBioMedicine
- Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer
- (2019) Triparna Sen et al. Cancer Discovery
- STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
- (2019) Hannah Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma
- (2019) Katey S. S. Enfield et al. Nature Communications
- Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
- (2019) Fengju Chen et al. Nature Communications
- Delicate regulation of the cGAS–MITA-mediated innate immune response
- (2018) Wei-Wei Luo et al. Cellular & Molecular Immunology
- Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production
- (2018) Hiroyasu Konno et al. ONCOGENE
- cGAS–STING and Cancer: Dichotomous Roles in Tumor Immunity and Development
- (2018) Kevin W. Ng et al. TRENDS IN IMMUNOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
- (2018) Shunsuke Kitajima et al. Cancer Discovery
- An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer
- (2018) Xiang An et al. Molecular Therapy-Nucleic Acids
- Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
- (2018) Luis M. Seijo et al. Journal of Thoracic Oncology
- STING-mediated DNA sensing in cancer immunotherapy
- (2017) Xiang Zhou et al. Science China-Life Sciences
- Decreased expression of STING predicts poor prognosis in patients with gastric cancer
- (2017) Shushu Song et al. Scientific Reports
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
- (2016) Henrique Lemos et al. CANCER RESEARCH
- The cGAS-STING Defense Pathway and Its Counteraction by Viruses
- (2016) Zhe Ma et al. Cell Host & Microbe
- Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
- (2016) Alicia Hulbert et al. CLINICAL CANCER RESEARCH
- Novel therapeutic targets on the horizon for lung cancer
- (2016) Wan-Ling Tan et al. LANCET ONCOLOGY
- Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
- (2016) Yang Bu et al. PLoS One
- MERAV: a tool for comparing gene expression across human tissues and cell types
- (2015) Yoav D. Shaul et al. NUCLEIC ACIDS RESEARCH
- Diverse roles of STING-dependent signaling on the development of cancer
- (2015) J Ahn et al. ONCOGENE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Protective role of STING against gliomagenesis: Rational use of STING agonist in anti-glioma immunotherapy
- (2015) Takayuki Ohkuri et al. OncoImmunology
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- (2014) Liufu Deng et al. IMMUNITY
- Cutting Edge: STING Mediates Protection against Colorectal Tumorigenesis by Governing the Magnitude of Intestinal Inflammation
- (2014) Qifan Zhu et al. JOURNAL OF IMMUNOLOGY
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- Adenosquamous lung carcinomas: A histologic subtype with poor prognosis
- (2011) Pier Luigi Filosso et al. LUNG CANCER
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More